Abstract
Trigger points in chronic pain and myofascial syndromes are often localized at a distance from the painful area. Infiltration of trigger points with Bupivacaine 0.5% greatly reduces pain and can eliminate it with no need of any other analgesic therapy.
Publication types
-
Case Reports
-
English Abstract
MeSH terms
-
Adolescent
-
Bupivacaine / therapeutic use
-
Female
-
Fibromyalgia / drug therapy
-
Fibromyalgia / etiology*
-
Humans
-
Myofascial Pain Syndromes / complications*
-
Myofascial Pain Syndromes / drug therapy